Yan Teng
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Emotional burden of TI-RADS 4 thyroid nodules: clinical and psychosocial correlation.
Journal: Gland surgery
Published: November 08, 2025
Correction: Case Report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma.
Journal: Frontiers in oncology
Published: October 22, 2025
Application of the Case-based Learning (CBL) and Multidisciplinary Team (MDT) Teaching Model in Oncology Graduate Education.
Journal: Medical science educator
Published: June 23, 2025
Generation and characterization of the Il11-Cre knock-in mouse.
Journal: Transgenic research
Published: March 07, 2025
Clinical characteristics and prognostic factors in patients with malignant melanoma: A Chinese prospective cohort study.
Journal: World journal of clinical oncology
Published: February 08, 2025
Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma.
Journal: Frontiers in oncology
Published: November 13, 2024
Generation of Slco1a4-CreERT2-tdTomato Knock-in Mice for Specific Cerebrovascular Endothelial Cell Targeting.
Journal: International journal of molecular sciences
Published: March 29, 2024
Identification of the metaphyseal skeletal stem cell building trabecular bone.
Journal: Science advances
Published: February 23, 2024
LncRNA DGUOK-AS1 Promotes Cell Progression in Lung Squamous Cell Carcinoma by Regulation of miR-653-5p/SLC6A15 Axis.
Journal: Molecular biotechnology
Published: September 20, 2023
Spatial and temporal expression pattern of somatostatin receptor 2 in mouse
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: August 16, 2023
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
Journal: Clinical and translational medicine
Published: June 15, 2023
Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study.
Journal: Annals of translational medicine
Published: November 23, 2022
Last Updated: 09/26/2026